Fujirebio Diagnostics, Inc.
Medical device contract manufacturer · Malvern, Pennsylvania, United States
Fujirebio Diagnostics, Inc. is a medical device contract manufacturer with a registered site in Malvern, Pennsylvania, United States. The US FDA lists 2 medical device sites registered to the company, with devices in clinical chemistry, immunology and clinical toxicology.
Fujirebio Diagnostics at a glance
What does Fujirebio Diagnostics do?
Medical specialties of its FDA-listed devices
Device types listed with the FDA
Where is Fujirebio Diagnostics located?
Registered site: Malvern, Pennsylvania, United States
- Malvern, PennsylvaniaFujirebio Diagnostics, Inc. · FDA device site
- Seguin, TexasFujirebio Diagnostics, Inc. · FDA device site
International sites registered with the FDA
Frequently asked questions about Fujirebio Diagnostics
Where is Fujirebio Diagnostics based?
Fujirebio Diagnostics, Inc. is based in Malvern, Pennsylvania, United States.
What does Fujirebio Diagnostics do?
Fujirebio Diagnostics, Inc. is a medical device contract manufacturer. Its FDA-listed medical devices fall under clinical chemistry, immunology and clinical toxicology.
How many FDA-registered sites does Fujirebio Diagnostics have?
The US FDA lists 2 registered sites for Fujirebio Diagnostics, Inc., plus sites in Sweden, Japan and Belgium.
Similar companies
- Click Therapeutics, Inc.New York City, New York, United States
- Baxter Healthcare CorporationRound Lake, Illinois, United States
- Minnetronix Medical, Inc.Saint Paul, Minnesota, United States
- Intelligent Hearing Systems CorpMiami, Florida, United States
- Medline Industries, LPNorth Mankato, Minnesota, United States
- Integra Lifesciences CorporationPlainsboro, New Jersey, United States
- C. R. Bard, Inc.Covington, Georgia, United States
- Smith & Nephew, Inc.Memphis, Tennessee, United States
Work with CROs and CDMOs like Fujirebio Diagnostics
Compare transparent quotes from research and manufacturing partners, then contract once. Free for buyers.
Compare quotesLast updated 2026-09-23. Data licences